sorafenib has been researched along with mefloquine hydrochloride in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (mefloquine hydrochloride) | Trials (mefloquine hydrochloride) | Recent Studies (post-2010) (mefloquine hydrochloride) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 145 | 1 | 38 |
| Protein | Taxonomy | sorafenib (IC50) | mefloquine hydrochloride (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 4.33 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 4.8356 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grimberg, BT; Hough, LB; Jaworska, MM; Phillips, JG; Zimmerman, PA | 1 |
1 other study(ies) available for sorafenib and mefloquine hydrochloride
| Article | Year |
|---|---|
Addressing the malaria drug resistance challenge using flow cytometry to discover new antimalarials.
Topics: Animals; Antimalarials; DNA, Protozoan; Drug Discovery; Drug Resistance; Erythrocytes; Flow Cytometry; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; RNA, Protozoan; Structure-Activity Relationship | 2009 |